As of 2024-12-15, the EV/EBITDA ratio of Pfizer Inc (PFE) is 10.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Pfizer's latest enterprise value is 211,570.61 mil USD. Pfizer's TTM EBITDA according to its financial statements is 20,036.00 mil USD. Dividing these 2 quantities gives us the above Pfizer EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 10.0x | 8.7x |
| Forward P/E multiples | 19.0x - 26.1x | 20.4x |
| Fair Price | (1.28) - 23.60 | 9.23 |
| Upside | -105.0% - -7.7% | -63.9% |
| Date | EV/EBITDA |
| 2024-12-13 | 10.56 |
| 2024-12-12 | 10.50 |
| 2024-12-11 | 10.46 |
| 2024-12-10 | 10.56 |
| 2024-12-09 | 10.71 |
| 2024-12-06 | 10.60 |
| 2024-12-05 | 10.59 |
| 2024-12-04 | 10.46 |
| 2024-12-03 | 10.55 |
| 2024-12-02 | 10.63 |
| 2024-11-29 | 10.74 |
| 2024-11-27 | 10.63 |
| 2024-11-26 | 10.61 |
| 2024-11-25 | 10.73 |
| 2024-11-22 | 10.58 |
| 2024-11-21 | 10.43 |
| 2024-11-20 | 10.38 |
| 2024-11-19 | 10.42 |
| 2024-11-18 | 10.36 |
| 2024-11-15 | 10.34 |
| 2024-11-14 | 10.68 |
| 2024-11-13 | 10.88 |
| 2024-11-12 | 10.73 |
| 2024-11-11 | 10.75 |
| 2024-11-08 | 10.88 |
| 2024-11-07 | 11.09 |
| 2024-11-06 | 11.06 |
| 2024-11-05 | 11.24 |
| 2024-11-04 | 11.18 |
| 2024-11-01 | 11.27 |
| 2024-10-31 | 11.33 |
| 2024-10-30 | 11.39 |
| 2024-10-29 | 11.37 |
| 2024-10-28 | 11.49 |
| 2024-10-25 | 11.37 |
| 2024-10-24 | 11.43 |
| 2024-10-23 | 11.49 |
| 2024-10-22 | 11.48 |
| 2024-10-21 | 11.51 |
| 2024-10-18 | 11.59 |
| 2024-10-17 | 11.60 |
| 2024-10-16 | 11.72 |
| 2024-10-15 | 11.65 |
| 2024-10-14 | 11.55 |
| 2024-10-11 | 11.57 |
| 2024-10-10 | 11.62 |
| 2024-10-09 | 11.86 |
| 2024-10-08 | 11.58 |
| 2024-10-07 | 11.58 |
| 2024-10-04 | 11.41 |